GleamWall
中文EN

MODD Modular Medical, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1074871 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-12.9%
TTM EPS YoY71.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-270.8%
ROA-212.7%
ROIC (approx.)-430.1%
Asset turnover—

Leverage & solvency

Liabilities / assets10.3%
Debt / equity0.00x
Current ratio4.46x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.92x
Accruals ratio-16.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q22026-09-302027Q12026-06-302026Q4*2026-03-312026Q32025-12-312026Q22025-09-302026Q12025-06-302025Q4*2025-03-312025Q32024-12-31
Income statement
Revenue————————
R&D expense$3.93M$4.37M$3.84M$5.41M$5.59M$5.13M$3.94M$3.85M
SG&A expense$3.21M$2.17M$1.84M$1.84M$2.24M$1.67M$1.04M$1.00M
Operating income-$7.14M-$6.54M-$5.68M-$7.24M-$7.83M-$6.80M-$4.98M-$4.85M
Pretax income-$7.10M—-$6.39M-$7.36M-$7.79M—-$4.93M-$4.80M
Income tax$2,000—$0$0$2,000—$0$0
Net income-$7.10M-$6.49M-$6.39M-$7.36M-$7.79M-$6.70M-$4.93M-$4.80M
EBITDA-$6.69M-$6.04M-$5.24M-$6.81M-$7.44M-$6.39M-$4.65M-$4.57M
EPS (basic)-0.90-1.19—-0.11-4.21-3.70—-0.13
EPS (diluted)-0.90-1.19—-0.11-4.21-3.70—-0.13
Weighted avg. shares (diluted)7.93M5.45M—65.93M1.85M1.81M—37.81M
Balance sheet
Cash & equivalents$5.10M$3.92M$6.94M$2.94M$5.32M$7.52M$13.10M$6.99M
Current assets$5.86M$4.84M$7.54M$3.47M$5.95M$8.29M$13.52M$7.33M
PP&E, net$6.69M$7.09M$6.87M$6.33M$6.46M$5.21M$4.45M$3.96M
Total assets$12.73M$12.25M$14.83M$10.26M$12.97M$14.17M$18.73M$12.15M
Current liabilities$1.31M$1.49M$1.87M$2.18M$4.04M$2.05M$1.26M$1.38M
Total liabilities$1.31M$1.49M$1.87M$4.38M$4.21M$2.33M$1.66M$1.89M
Shareholders' equity$11.42M$10.76M$12.96M$5.88M$8.77M$11.84M$17.08M$10.26M
Shares outstanding9.50M5.57M4.66M77.70M61.17M55.27M1.79M40.66M
Cash flow statement
Operating cash flow-$6.28M-$5.97M-$5.82M-$7.16M-$5.41M-$5.37M-$4.31M-$4.10M
Capital expenditure$88,000$688,000$1.00M$1.22M$771,000$934,000$948,000$542,000
Free cash flow-$6.37M-$6.66M-$6.82M-$8.38M-$6.18M-$6.31M-$5.26M-$4.64M
Investing cash flow-$88,000-$688,000-$1.00M-$1.22M-$771,000-$934,000-$948,000-$542,000
Financing cash flow$7.55M$3.64M$10.82M$6.00M$3.98M$733,000$11.37M$7.73M
Depreciation & amortization$447,000$501,000$441,000$430,000$391,000$410,000$326,000$281,000
Stock-based compensation$307,000$447,000-$293,000$2,000$4,000$724,000$374,000$5,000

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.